North America Biosimulation Market Size, Share & Trends Analysis Report By Product, By Pricing Model, By End Use, By Application, By Deployment Model, By Therapeutic Area, By Country and Growth Forecast, 2024

List of Tables

The North America Biosimulation Market would witness market growth of 16.1% CAGR during the forecast period (2024-2031).

The US market dominated the North America Biosimulation Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,575.5 million by 2031. The Canada market is experiencing a CAGR of 18.7% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 17.7% during (2024 - 2031).

This market is at the forefront of a transformative wave in the healthcare and pharmaceutical industries. This cutting-edge field combines computational science with biology to simulate complex biological systems, offering unprecedented insights into drug development, disease progression, and therapeutic responses.

At its core, they involves creating virtual models of biological systems, enabling scientists to study the intricate processes of the human body without the need for extensive laboratory experiments. This capability has revolutionized pharmaceutical research by allowing researchers to simulate how drugs interact with biological pathways, predict outcomes, and optimize dosing regimens.

Due to growing healthcare expenditures and a changing private healthcare industry, Mexico is becoming a major player in the North American market. The country's increasing disease burden, such as the projected rise in diabetes cases from 12.8 million in 2019 to 22.3 million by 2045, underscores the critical need for advanced healthcare solutions. These platforms play a vital role in helping healthcare providers optimize drug therapies and manage chronic diseases more effectively. These tools and lifestyle disease management applications are crucial for addressing this growing health crisis. Therefore, with increasing investments in personalized medicine, biologics, and rare disease therapies, North America remains a key driver of growth in the global biosimulation landscape.

Based on Product, the market is segmented into Software (Molecular Modeling & Simulation Software, Clinical Trial Design Software, PK/PD Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Toxicity Prediction Software, and Other Software Type) and Services (Contract Services, Consulting, and Other Services Type). Based on Pricing Model, the market is segmented into License-based Model, Subscription-based Model, Service-based Model, and Pay Per Use Model. Based on End Use, the market is segmented into Life Sciences Companies, Academic Research Institutions, and Other End Use. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling, and Other Application. Based on Deployment Model, the market is segmented into Cloud-based, On-premises, and Hybrid Model. Based on Therapeutic Area, the market is segmented into Oncology, Cardiovascular Disease, Infectious Disease, Neurological Disorders, and Other Therapeutic Area. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Certara, Inc.
Dassault Systemes SE
Advanced Chemistry Development, Inc.
Genedata AG (Danaher Corporation)
Instem Group of Companies
Chemical Computing Group ULC
Simulations Plus, Inc.
Schrodinger, Inc.
PPD, Inc. (Thermo Fisher Scientific, Inc.)
Physiomics Plc

North America Biosimulation Market Report Segmentation

By Product

Software
- Molecular Modeling & Simulation Software
- Clinical Trial Design Software
- PK/PD Modeling and Simulation Software
- Pbpk Modeling and Simulation Software
- Toxicity Prediction Software
- Other Software Type
Services
- Contract Services
- Consulting
- Other Services Type

By Pricing Model

License-based Model
Subscription-based Model
Service-based Model
Pay Per Use Model

By End Use

Life Sciences Companies
Academic Research Institutions
Other End Use

By Application

Drug Discovery & Development
Disease Modeling
Other Application

By Deployment Model

Cloud-based
On-premises
Hybrid Model

By Therapeutic Area

Oncology
Cardiovascular Disease
Infectious Disease
Neurological Disorders
Other Therapeutic Area

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Biosimulation Market, by Product
- 1.4.2 North America Biosimulation Market, by Pricing Model
- 1.4.3 North America Biosimulation Market, by End Use
- 1.4.4 North America Biosimulation Market, by Application
- 1.4.5 North America Biosimulation Market, by Deployment Model
- 1.4.6 North America Biosimulation Market, by Therapeutic Area
- 1.4.7 North America Biosimulation Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 Market Share Analysis, 2023
4.2 Strategies Deployed in Biosimulation Market
4.3 Porter Five Forces Analysis

Chapter 5. North America Biosimulation Market by Product

5.1 North America Software Market by Region
5.2 North America Biosimulation Market by Software Type
- 5.2.1 North America Molecular Modeling & Simulation Software Market by Country
- 5.2.2 North America Clinical Trial Design Software Market by Country
- 5.2.3 North America PK/PD Modeling and Simulation Software Market by Country
- 5.2.4 North America Pbpk Modeling and Simulation Software Market by Country
- 5.2.5 North America Toxicity Prediction Software Market by Country
- 5.2.6 North America Other Software Type Market by Country
5.3 North America Services Market by Region
5.4 North America Biosimulation Market by Services Type
- 5.4.1 North America Contract Services Market by Country
- 5.4.2 North America Consulting Market by Country
- 5.4.3 North America Other Services Type Market by Country

Chapter 6. North America Biosimulation Market by Pricing Model

6.1 North America License-based Model Market by Country
6.2 North America Subscription-based Model Market by Country
6.3 North America Service-based Model Market by Country
6.4 North America Pay Per Use Model Market by Country

Chapter 7. North America Biosimulation Market by End Use

7.1 North America Life Sciences Companies Market by Country
7.2 North America Academic Research Institutions Market by Country
7.3 North America Other End Use Market by Country

Chapter 8. North America Biosimulation Market by Application

8.1 North America Drug Discovery & Development Market by Country
8.2 North America Disease Modeling Market by Country
8.3 North America Other Application Market by Country

Chapter 9. North America Biosimulation Market by Deployment Model

9.1 North America Cloud-based Market by Country
9.2 North America On-premises Market by Country
9.3 North America Hybrid Model Market by Country

Chapter 10. North America Biosimulation Market by Therapeutic Area

10.1 North America Oncology Market by Country
10.2 North America Cardiovascular Disease Market by Country
10.3 North America Infectious Disease Market by Country
10.4 North America Neurological Disorders Market by Country
10.5 North America Other Therapeutic Area Market by Country

Chapter 11. North America Biosimulation Market by Country

11.1 US Biosimulation Market
- 11.1.1 US Biosimulation Market by Product
  - 11.1.1.1 US Biosimulation Market by Software Type
  - 11.1.1.2 US Biosimulation Market by Services Type
- 11.1.2 US Biosimulation Market by Pricing Model
- 11.1.3 US Biosimulation Market by End Use
- 11.1.4 US Biosimulation Market by Application
- 11.1.5 US Biosimulation Market by Deployment Model
- 11.1.6 US Biosimulation Market by Therapeutic Area
11.2 Canada Biosimulation Market
- 11.2.1 Canada Biosimulation Market by Product
  - 11.2.1.1 Canada Biosimulation Market by Software Type
  - 11.2.1.2 Canada Biosimulation Market by Services Type
- 11.2.2 Canada Biosimulation Market by Pricing Model
- 11.2.3 Canada Biosimulation Market by End Use
- 11.2.4 Canada Biosimulation Market by Application
- 11.2.5 Canada Biosimulation Market by Deployment Model
- 11.2.6 Canada Biosimulation Market by Therapeutic Area
11.3 Mexico Biosimulation Market
- 11.3.1 Mexico Biosimulation Market by Product
  - 11.3.1.1 Mexico Biosimulation Market by Software Type
  - 11.3.1.2 Mexico Biosimulation Market by Services Type
- 11.3.2 Mexico Biosimulation Market by Pricing Model
- 11.3.3 Mexico Biosimulation Market by End Use
- 11.3.4 Mexico Biosimulation Market by Application
- 11.3.5 Mexico Biosimulation Market by Deployment Model
- 11.3.6 Mexico Biosimulation Market by Therapeutic Area
11.4 Rest of North America Biosimulation Market
- 11.4.1 Rest of North America Biosimulation Market by Product
  - 11.4.1.1 Rest of North America Biosimulation Market by Software Type
  - 11.4.1.2 Rest of North America Biosimulation Market by Services Type
- 11.4.2 Rest of North America Biosimulation Market by Pricing Model
- 11.4.3 Rest of North America Biosimulation Market by End Use
- 11.4.4 Rest of North America Biosimulation Market by Application
- 11.4.5 Rest of North America Biosimulation Market by Deployment Model
- 11.4.6 Rest of North America Biosimulation Market by Therapeutic Area

Chapter 12. Company Profiles

12.1 Certara, Inc.
- 12.1.1 Company Overview
- 12.1.2 Financial Analysis
- 12.1.3 Regional Analysis
- 12.1.4 Research & Development Expenses
- 12.1.5 Recent strategies and developments:
  - 12.1.5.1 Product Launches and Product Expansions:
  - 12.1.5.2 Acquisition and Mergers:
- 12.1.6 SWOT Analysis
12.2 Dassault Systemes SE
- 12.2.1 Company Overview
- 12.2.2 Financial Analysis
- 12.2.3 Regional Analysis
- 12.2.4 Research & Development Expense
- 12.2.5 SWOT Analysis
12.3 Advanced Chemistry Development, Inc.
- 12.3.1 Company Overview
12.4 Genedata AG (Danaher Corporation)
- 12.4.1 Company Overview
- 12.4.2 Financial Analysis
- 12.4.3 Segmental and Regional Analysis
- 12.4.4 Research & Development Expense
- 12.4.5 Recent strategies and developments:
  - 12.4.5.1 Partnerships, Collaborations, and Agreements:
12.5 Instem Group of Companies
- 12.5.1 Company Overview
12.6 Chemical Computing Group ULC
- 12.6.1 Company Overview
12.7 Simulations Plus, Inc.
- 12.7.1 Company Overview
- 12.7.2 Financial Analysis
- 12.7.3 Segmental and Regional Analysis
- 12.7.4 Research & Development Expenses
- 12.7.5 Recent strategies and developments:
  - 12.7.5.1 Partnerships, Collaborations, and Agreements:
  - 12.7.5.2 Product Launches and Product Expansions:
  - 12.7.5.3 Acquisition and Mergers:
- 12.7.6 SWOT Analysis
12.8 Schrodinger, Inc.
- 12.8.1 Company Overview
- 12.8.2 Financial Analysis
- 12.8.3 Segmental and Regional Analysis
- 12.8.4 Research & Development Expenses
12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
- 12.9.1 Company Overview
- 12.9.2 Financial Analysis
- 12.9.3 Segmental and Regional Analysis
- 12.9.4 Research & Development Expenses
12.10. Physiomics Plc
- 12.10.1 Company Overview
- 12.10.2 Financial Analysis

LIST OF TABLES

TABLE 1 North America Biosimulation Market, 2020 - 2023, USD Million
TABLE 2 North America Biosimulation Market, 2024 - 2031, USD Million
TABLE 3 North America Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 4 North America Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 5 North America Software Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Software Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 8 North America Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 9 North America Molecular Modeling & Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Molecular Modeling & Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Clinical Trial Design Software Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Clinical Trial Design Software Market by Country, 2024 - 2031, USD Million
TABLE 13 North America PK/PD Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 14 North America PK/PD Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Pbpk Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Pbpk Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Toxicity Prediction Software Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Toxicity Prediction Software Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Other Software Type Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Other Software Type Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Services Market by Region, 2020 - 2023, USD Million
TABLE 22 North America Services Market by Region, 2024 - 2031, USD Million
TABLE 23 North America Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 24 North America Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 25 North America Contract Services Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Contract Services Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Consulting Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Consulting Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Other Services Type Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Other Services Type Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 32 North America Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 33 North America License-based Model Market by Country, 2020 - 2023, USD Million
TABLE 34 North America License-based Model Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Subscription-based Model Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Subscription-based Model Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Service-based Model Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Service-based Model Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Pay Per Use Model Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Pay Per Use Model Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 42 North America Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 43 North America Life Sciences Companies Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Life Sciences Companies Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Academic Research Institutions Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Academic Research Institutions Market by Country, 2024 - 2031, USD Million
TABLE 47 North America Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 48 North America Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 49 North America Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 50 North America Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 51 North America Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 52 North America Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 53 North America Disease Modeling Market by Country, 2020 - 2023, USD Million
TABLE 54 North America Disease Modeling Market by Country, 2024 - 2031, USD Million
TABLE 55 North America Other Application Market by Country, 2020 - 2023, USD Million
TABLE 56 North America Other Application Market by Country, 2024 - 2031, USD Million
TABLE 57 North America Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 58 North America Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 59 North America Cloud-based Market by Country, 2020 - 2023, USD Million
TABLE 60 North America Cloud-based Market by Country, 2024 - 2031, USD Million
TABLE 61 North America On-premises Market by Country, 2020 - 2023, USD Million
TABLE 62 North America On-premises Market by Country, 2024 - 2031, USD Million
TABLE 63 North America Hybrid Model Market by Country, 2020 - 2023, USD Million
TABLE 64 North America Hybrid Model Market by Country, 2024 - 2031, USD Million
TABLE 65 North America Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 66 North America Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 67 North America Oncology Market by Country, 2020 - 2023, USD Million
TABLE 68 North America Oncology Market by Country, 2024 - 2031, USD Million
TABLE 69 North America Cardiovascular Disease Market by Country, 2020 - 2023, USD Million
TABLE 70 North America Cardiovascular Disease Market by Country, 2024 - 2031, USD Million
TABLE 71 North America Infectious Disease Market by Country, 2020 - 2023, USD Million
TABLE 72 North America Infectious Disease Market by Country, 2024 - 2031, USD Million
TABLE 73 North America Neurological Disorders Market by Country, 2020 - 2023, USD Million
TABLE 74 North America Neurological Disorders Market by Country, 2024 - 2031, USD Million
TABLE 75 North America Other Therapeutic Area Market by Country, 2020 - 2023, USD Million
TABLE 76 North America Other Therapeutic Area Market by Country, 2024 - 2031, USD Million
TABLE 77 North America Biosimulation Market by Country, 2020 - 2023, USD Million
TABLE 78 North America Biosimulation Market by Country, 2024 - 2031, USD Million
TABLE 79 US Biosimulation Market, 2020 - 2023, USD Million
TABLE 80 US Biosimulation Market, 2024 - 2031, USD Million
TABLE 81 US Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 82 US Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 83 US Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 84 US Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 85 US Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 86 US Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 87 US Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 88 US Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 89 US Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 90 US Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 91 US Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 92 US Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 93 US Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 94 US Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 95 US Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 96 US Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 97 Canada Biosimulation Market, 2020 - 2023, USD Million
TABLE 98 Canada Biosimulation Market, 2024 - 2031, USD Million
TABLE 99 Canada Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 100 Canada Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 101 Canada Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 102 Canada Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 103 Canada Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 104 Canada Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 105 Canada Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 106 Canada Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 107 Canada Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 108 Canada Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 109 Canada Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 110 Canada Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 111 Canada Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 112 Canada Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 113 Canada Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 114 Canada Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 115 Mexico Biosimulation Market, 2020 - 2023, USD Million
TABLE 116 Mexico Biosimulation Market, 2024 - 2031, USD Million
TABLE 117 Mexico Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 118 Mexico Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 119 Mexico Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 120 Mexico Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 121 Mexico Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 122 Mexico Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 123 Mexico Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 124 Mexico Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 125 Mexico Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 126 Mexico Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 127 Mexico Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 128 Mexico Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 129 Mexico Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 130 Mexico Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 131 Mexico Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 132 Mexico Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 133 Rest of North America Biosimulation Market, 2020 - 2023, USD Million
TABLE 134 Rest of North America Biosimulation Market, 2024 - 2031, USD Million
TABLE 135 Rest of North America Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 136 Rest of North America Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 137 Rest of North America Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 138 Rest of North America Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 139 Rest of North America Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 140 Rest of North America Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 141 Rest of North America Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 142 Rest of North America Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 143 Rest of North America Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 144 Rest of North America Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 145 Rest of North America Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 146 Rest of North America Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 147 Rest of North America Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 148 Rest of North America Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 149 Rest of North America Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 150 Rest of North America Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 151 Key Information - Certara, Inc.
TABLE 152 Key Information - Dassault Systemes SE
TABLE 153 Key Information - Advanced Chemistry Development, Inc.
TABLE 154 Key Information - Genedata AG
TABLE 155 Key Information - Instem Group of Companies
TABLE 156 Key Information - Chemical Computing Group ULC
TABLE 157 Key Information - Simulations Plus, Inc.
TABLE 158 Key Information - Schrodinger, Inc.
TABLE 159 Key Information - PPD, Inc.
TABLE 160 Key Information - Physiomics Plc

North America Biosimulation Market Size, Share & Trends Analysis Report By Product, By Pricing Model, By End Use, By Application, By Deployment Model, By Therapeutic Area, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents